Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemours (CC) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to 6.29%.

  • Chemours' EBITDA Margin rose 50300.0% to 6.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year decrease of 43200.0%. This contributed to the annual value of 0.47% for FY2024, which is 15700.0% up from last year.
  • As of Q3 2025, Chemours' EBITDA Margin stood at 6.29%, which was up 50300.0% from 12.69% recorded in Q2 2025.
  • In the past 5 years, Chemours' EBITDA Margin ranged from a high of 17.23% in Q1 2022 and a low of 23.86% during Q2 2023
  • Its 5-year average for EBITDA Margin is 4.76%, with a median of 6.29% in 2025.
  • As far as peak fluctuations go, Chemours' EBITDA Margin crashed by -351900bps in 2023, and later skyrocketed by 319000bps in 2024.
  • Over the past 5 years, Chemours' EBITDA Margin (Quarter) stood at 12.89% in 2021, then tumbled by -105bps to 0.67% in 2022, then skyrocketed by 35bps to 0.44% in 2023, then soared by 1123bps to 4.49% in 2024, then skyrocketed by 40bps to 6.29% in 2025.
  • Its EBITDA Margin stands at 6.29% for Q3 2025, versus 12.69% for Q2 2025 and 3.87% for Q1 2025.